Assessment of vascular disease has evolved from mere indirect and direct measurements of luminal stenosis to sophisticated imaging methods to depict millimeter structural changes of the vasculature. In the near future, the emergence of multimodal molecular imaging strategies may enable robust therapeutic and diagnostic (‘theragnostic’) approaches to vascular diseases that comprehensively consider structural, functional, biological and genomic characteristics of the disease in individualized risk assessment, early diagnosis and delivery of targeted interventions.This review presents a summary of recent preclinical and clinical developments in molecular imaging and theragnostic applications covering diverse atherosclerosis events such as endothelial activation, macrophage inflammatory activity, plaque neovascularization and arterial thrombosis. The main focus is on molecular targets designed for imaging platforms commonly used in clinical medicine including magnetic resonance, computed tomography and positron emission tomography. A special emphasis is given to vascular ultrasound applications, considering the important role this imaging platform plays in the clinical and research practice of the vascular medicine specialty.
Williams KJ, Tabas I.The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol1995; 15: 551-561.
6.
Tabas I., Williams KJ, Boren J.Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation2007; 116: 1832-1844.
7.
Hansson GKInflammation, atherosclerosis, and coronary artery disease. N Engl J Med2005; 352: 1685-1695.
8.
Cybulsky MI , Gimbrone MA Jr.Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science1991; 251: 788-791.
9.
Massberg S. , Brand K., Gruner S., et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med2002; 196: 887-896.
10.
May AE, Seizer P., Gawaz M.Platelets: inflammatory fire-bugs of vascular walls. Arterioscler Thromb Vasc Biol2008; 28: s5-10.
11.
Boring L., Gosling J., Cleary M., Charo IFDecreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature1998; 394: 894-897.
12.
Li AC, Glass CKThe macrophage foam cell as a target for therapeutic intervention . Nat Med2002; 8: 1235-1242.
13.
Den Dekker WK, Cheng C., Pasterkamp G., Duckers HJToll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis2010;2: 314-320.
14.
Linton MF, Fazio S.Class A scavenger receptors, macrophages, and atherosclerosis. Curr Opin Lipidol2001; 12: 489-495.
15.
Virmani R., Burke AP, Farb A., Kolodgie FDPathology of the unstable plaque. Prog Cardiovasc Dis2002; 44: 349-356.
16.
Whatling C. , Bjork H., Gredmark S., Hamsten A., Eriksson P.Effect of macrophage differentiation and exposure to mildly oxidized LDL on the proteolytic repertoire of THP-1 monocytes. J Lipid Res2004; 45: 1768-1776.
17.
Volcik KA, Campbell S., Chambless LE, et al. MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study. Atherosclerosis2010;210: 188-193.
18.
Feinstein SBContrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. J Am Coll Cardiol2006; 48: 236-243.
19.
Kaufmann BA , Sanders JM, Davis C., et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation2007 ; 116: 276-284.
20.
Gramiak R., Shah PMEchocardiography of the aortic root. Invest Radiol1968; 3: 356-366.
21.
Lindner JR, Song J., Jayaweera AR, Sklenar J., Kaul S.Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr2002 ; 15: 396-403.
22.
Villanueva FSMolecular imaging of cardiovascular disease using ultrasound. J Nucl Cardiol2008; 15: 576-586.
23.
Kaufmann BA , Lindner JRMolecular imaging with targeted contrast ultrasound . Curr Opin Biotech2007 ; 18: 11-16.
24.
Xiong L., Deng YB, Zhu Y., Liu YN, Bi XJCorrelation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology2009; 251: 583-589.
25.
Kalantarinia K., Belcik JT, Patrie JT, Wei K.Real-time measurement of renal blood flow in healthy subjects using contrast-enhanced ultrasound . Am J Physiol Renal Physiol2009; 297: F1129-1134.
26.
Duerschmied D., Olson L., Olschewski M., et al. Contrast ultrasound perfusion imaging of lower extremities in peripheral arterial disease: a novel diagnostic method . Eur Heart J2006; 27: 310-315.
27.
Porter TR, Xie F., Silver M., Kricsfeld D., O’Leary E.Real-time perfusion imaging with low mechanical index pulse inversion Doppler imaging. J Am Coll Cardiol2001; 37: 748-753.
28.
Stride E.Physical principles of microbubbles for ultrasound imaging and therapy . Cerebrovasc Dis 2009;27(suppl 2):1-13.
Miller DL, Averkiou MA, Brayman AA, et al. Bioeffects considerations for diagnostic ultrasound contrast agents. J Ultrasound Med2008; 27: 611-632.
31.
Kurt M., Shaikh KA, Peterson L., et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol2009; 53: 802-810.
32.
Wei K., Mulvagh SL, Carson L., et al. The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr2008; 21: 1202-1206.
33.
Abdelmoneim SS, Bernier M., Scott CG, et al. Safety of contrast agent use during stress echocardiography: a 4-year experience from a single-center cohort study of 26,774 patients. JACC Cardiovasc Imaging2009; 2: 1048-1056.
34.
Weyman AEThe year in echocardiography. J Am Coll Cardiol2009; 53: 1558-1567.
35.
Keske MA, Clerk LH, Price WJ, Jahn LA, Barrett EJObesity blunts microvascular recruitment in human forearm muscle after a mixed meal. Diabetes Care2009; 32: 1672-1677.
36.
Womack L., Peters D., Barrett EJ, Kaul S., Price W., Lindner JRAbnormal skeletal muscle capillary recruitment during exercise in patients with type 2 diabetes mellitus and microvascular complications. J Am Coll Cardiol2009; 53: 2175-2183.
37.
Fleiner M., Kummer M., Mirlacher M., et al. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation2004; 110: 2843-2850.
38.
Staub D., Schinkel AF, Coll B., et al. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging2010;3: 761-771.
39.
Vela D., Buja LM, Madjid M., et al. The role of periadventitial fat in atherosclerosis. Arch Pathol Lab Med2007; 131: 481-487.
40.
Herrmann J. , Lerman LO, Rodriguez-Porcel M., et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res2001; 51: 762-766.
41.
Sluimer JC, Gasc JM, van Wanroij JL, et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis . J Am Coll Cardiol2008; 51: 1258-1265.
42.
Schinkel AF , Krueger CG, Tellez A., et al. Contrast-enhanced ultrasound for imaging vasa vasorum: comparison with histopathology in a swine model of atherosclerosis . Eur J Echocardiogr2010;11: 659-664.
43.
Vicenzini E. , Giannoni MF, Puccinelli F., et al. Detection of carotid adventitial vasa vasorum and plaque vascularization with ultrasound cadence contrast pulse sequencing technique and echo-contrast agent. Stroke2007; 38: 2841-2843.
44.
Giannoni MF , Vicenzini E., Citone M., et al. Contrast carotid ultrasound for the detection of unstable plaques with neoangiogenesis: a pilot study. Eur J Vasc Endovasc Surg2009; 37: 722-727.
45.
Magnoni M., Coli S., Marrocco-Trischitta MM, et al. Contrast-enhanced ultrasound imaging of periadventitial vasa vasorum in human carotid arteries. Eur J Echocardiogr2009; 10: 260-264.
46.
Shah F., Balan P., Weinberg M., et al. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis?Vasc Med2007; 12: 291-297.
47.
Lindner JRContrast ultrasound molecular imaging of inflammation in cardiovascular disease . Cardiovasc Res2009; 84: 182-189.
48.
Fisher NG, Christiansen JP, Klibanov A., Taylor RP, Kaul S., Lindner JRInfluence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol2002 ; 40: 811-819.
49.
Tsutsui JM, Xie F., Cano M., et al. Detection of retained microbubbles in carotid arteries with real-time low mechanical index imaging in the setting of endothelial dysfunction . J Am Coll Cardiol2004; 44: 1036-1046.
50.
Kaufmann BA , Carr CL, Belcik JT, et al. Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol2010;30: 54-59.
51.
Hamilton AJ , Huang S.-L, Warnick D., et al. Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol2004; 43: 453-460.
52.
Kooi ME, Cappendijk VC, Cleutjens Kbjm, et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation2003; 107: 2453-2458.
53.
Trivedi RA, Mallawarachi C., U-King-Im JM, et al. Identifying inflamed carotid plaques using in vivo USPIOenhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol2006; 26: 1601-1606.
54.
Tang TY, Howarth SPS, Miller SR, et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study: evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol2009; 53: 2039-2050.
55.
Tang TY, Muller KH, Graves MJ, et al. Iron oxide particles for atheroma imaging. Arterioscler Thromb Vasc Biol2009; 29: 1001-1008.
56.
Von zur Muhlen C., von Elverfeldt D., Bassler N., et al. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis2007; 193: 102-111.
57.
Nicolau B., Catherine C., Anna Louise B., et al. In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology2009; 1: 272-298.
Stadler N., Lindner RA, Davies MJDirect detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol2004; 24: 949-954.
60.
David PC, Karen CB-S, Willem JMM, et al. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. Small2008; 4: 1437-1444.
61.
Briley-Saebo KC, Shaw PX, Mulder WJM, et al. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation2008 ; 117: 3206-3215.
62.
Townsend D. , Cherry S.Combining anatomy and function: the path to true image fusion. Eur Radiol2001; 11: 1968-1974.
63.
Alexanderson E., Slomka P., Cheng V., et al. Fusion of positron emission tomography and coronary computed tomographic angiography identifies fluorine 18 fluorodeoxyglucose uptake in the left main coronary artery soft plaque. J Nucl Cardiol2008; 15: 841-843.
64.
Libby P.Inflammation in atherosclerosis. Nature2002 ; 420: 868-874.
65.
Ogawa M., Ishino S., Mukai T., et al. 18F-FDG Accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med2004; 45: 1245-1250.
Zhang Z., Machac J., Helft G., et al. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med2006; 6: 3.
68.
Yun M., Yeh D., Araujo LI, Jang S., Newberg A., Alavi A.F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med2001; 26: 314-319.
69.
Tawakol A., Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients . J Am Coll Cardiol2006; 48: 1818-1824.
70.
Tahara N., Kai H., Ishibashi M., et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol2006; 48: 1825-1831.
71.
Pedersen SF , Graebe M., Fisker Hag AM, Hojgaard L., Sillesen H., Kjaer A.Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun2010; 31: 423-429.
72.
Zhao S., Kuge Y., Tsukamoto E., et al. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions. Eur J Nucl Med2001; 28: 730.
73.
Devine CE, Mawlawi O.Radiation safety with positron emission tomography and computed tomography . Semin Ultrasound CT MR2010;31: 39-45.
74.
Brenner DJ, Hall EJComputed tomography-an increasing source of radiation exposure. N Engl J Med2007; 357: 2277-2284.
75.
Nieswandt B. , Watson SPPlatelet-collagen interaction: is GPVI the central receptor?Blood2003; 102: 449-461.
76.
Mazzucato M. , Cozzi MR, Battiston M., et al. Distinct spatio-temporal Ca2+ signaling elicited by integrin {alpha}2{beta}1 and glycoprotein VI under flow. Blood2009; 114: 2793-2801.
77.
Klink A., Lancelot E., Ballet S., et al. Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe. Arterioscler Thromb Vasc Biol2010;30: 403-410.
78.
Tait JF, Cerqueira MD, Dewhurst TA, Fujikawa K., Ritchie JL, Stratton JREvaluation of annexin V as a platelet-directed thrombus targeting agent. Thromb Res1994; 75: 491-501.
79.
Von zur Muhlen C., Peter K., Ali ZA, et al. Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa. J Vasc Res2009; 46: 6-14.
80.
Schumann PAB , Christiansen Jpcm, Quigley RMB , et al. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol2002; 37: 587-593.
81.
Thiagarajan P. , Tait JFBinding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem1990; 265: 17,420-17,423.
Alonso A., Della Martina A., Stroick M., et al. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke2007; 38: 1508-1514.
84.
Martin MJ, Chung EML, Goodall AH, et al. Enhanced detection of thromboemboli with the use of targeted microbubbles. Stroke2007; 38: 2726-2732.
85.
Rao R., Nanda S.Sonophoresis: recent advancements and future trends. J Pharm Pharmacol2009; 61: 689-705.
Slikkerveer J., Dijkmans P., Sieswerda G., et al. Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: rationale and design of the Sonolysis study. Trials2008; 9: 72.
88.
Bookstein JJ , Saldinger E.Accelerated thrombolysis: in vitro evaluation of agents and methods of administration. Invest Radiol1985; 20: 731-735.
89.
Francis CW, Blinc A., Lee S., Cox C.Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol1995; 21: 419-424.
Alexandrov AV, Demchuk AM, Felberg RA, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke2000; 31: 610-614.
93.
Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med2004 ; 351: 2170-2178.
94.
Alexandrov AVUltrasound enhancement of fibrinolysis. Stroke2009;40(3suppl1): S107-110.
95.
Tsivgoulis G., Eggers J., Ribo M., et al. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke2010;41: 280-287.
96.
Mayer CR, Bekeredjian R.Ultrasonic gene and drug delivery to the cardiovascular system. Adv Drug Deliv Rev2008; 60: 1177-1192.
Tachibana K. , Tachibana S.Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation1995; 92: 1148-1150.
99.
Xie F., Lof J., Matsunaga T., Zutshi R., Porter TRDiagnostic ultrasound combined with glycoprotein IIb/IIIa-targeted microbubbles improves microvascular recovery after acute coronary thrombotic occlusions . Circulation2009; 119: 1378-1385.
100.
Leong-Poi H., Kuliszewski MA, Lekas M., et al. Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res2007; 101: 295-303.
101.
Kobulnik J. , Kuliszewski MA, Stewart DJ, Lindner JR, Leong-Poi H.Comparison of gene delivery techniques for therapeutic angiogenesis: ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection . J Am Coll Cardiol2009; 54: 1735-1742.
102.
Suzuki J., Ogawa M., Takayama K., et al. Ultrasound-microbubble-mediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice. J Am Coll Cardiol2010;55: 904-913.
103.
Seip R., Chien Ting C., Hall CS, Raju BI, Ghanem A., Tiemann K.Targeted ultrasound-mediated delivery of nanoparticles: on the development of a new HIFU-based therapy and imaging device. IEEE Trans Biomed Eng2009; 57: 61-70.
104.
Sun C. , Lee JSH, Zhang M.Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev2008; 60: 1252-1265.
